Project description
Multiple sclerosis immune cell characterisation to provide new disease biomarker
Currently, there is no biomarker for monitoring the progression of the chronic inflammatory disease multiple sclerosis (MS). To address this, scientists of the EU-funded IMPACT project will investigate the immune compartment of patients at a single cell level using machine learning approaches. They will also eliminate the impact of an individual's genetic makeup on disease signature by studying a unique cohort of monozygotic twin pairs. Results will help unveil disease-specific signals and undertake a more precise characterisation of immune cell populations implicated in MS pathology. Ultimately, the study will lead to the identification of biomarkers that could be routinely used in the clinic.
Field of science
- /medical and health sciences/medical biotechnology/cells technologies/stem cells
- /medical and health sciences/health sciences/inflammatory diseases
- /medical and health sciences/basic medicine/neurology/multiple sclerosis
- /natural sciences/biological sciences/neurobiology
Topic(s)
Call for proposal
ERC-2019-ADG
See other projects for this call
Funding Scheme
ERC-ADG - Advanced GrantHost institution
UNIVERSITAT ZURICH
Address
Ramistrasse 71
8006 Zurich
Switzerland
8006 Zurich
Switzerland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 2 492 221
Beneficiaries (1)
UNIVERSITAT ZURICH
Switzerland
EU contribution
€ 2 492 221
Address
Ramistrasse 71
8006 Zurich
8006 Zurich
Activity type
Higher or Secondary Education Establishments
